{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:24:32Z","timestamp":1790645072083,"version":"4.1.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T00:00:00Z","timestamp":1652486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T00:00:00Z","timestamp":1652486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00277-022-04867-y","type":"journal-article","created":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T20:02:38Z","timestamp":1652558558000},"page":"1645-1654","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["L-glutamine for sickle cell disease: more than reducing redox"],"prefix":"10.1007","volume":"101","author":[{"given":"Firas","family":"Jafri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyuhee","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Cimpeanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Poplawska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibyendu","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seah H.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,14]]},"reference":[{"key":"4867_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","volume":"14","author":"P Sundd","year":"2019","unstructured":"Sundd P, Gladwin MT, Novelli EM (2019) Pathophysiology of sickle cell disease. Annu Rev Pathol 14:263\u2013292. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-012418-012838","journal-title":"Annu Rev Pathol"},{"key":"4867_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s12967-021-03074-z","volume":"19","author":"T Jang","year":"2012","unstructured":"Jang T, Poplawska M, Cimpeanu E, Mo G, Dutta D, Lim SH (2012) Vaso-occlusive crisis in sickle cell disease: a vicious cycle of secondary events. J Transl Med 19:397. https:\/\/doi.org\/10.1186\/s12967-021-03074-z","journal-title":"J Transl Med"},{"key":"4867_CR3","doi-asserted-by":"publisher","first-page":"096368972110465","DOI":"10.1177\/09636897211046559","volume":"30","author":"T Jang","year":"2021","unstructured":"Jang T, Mo G, Stewart C, Khoury L, Ferguson N, Egini O, Muthu J, Dutta D, Salifu M, Lim SH (2021) Hematopoietic stem cell transplant for sickle cell disease: patient selection and timing based on sickle cell-related multiple chronic conditions. Cell Transplant 30:09636897211046559. https:\/\/doi.org\/10.1177\/09636897211046559","journal-title":"Cell Transplant"},{"key":"4867_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/003335491312800206","volume":"128","author":"S Lanzkron","year":"2013","unstructured":"Lanzkron S, Carroll CP, Haywood C Jr (2013) Mortality rates and age at death from sickle cell disease: U.S., 1979\u20132005. Public Health Rep 128:110\u2013116. https:\/\/doi.org\/10.1177\/003335491312800206","journal-title":"Public Health Rep"},{"key":"4867_CR5","first-page":"1","volume":"58","author":"E Arias","year":"2010","unstructured":"Arias E, Rostron BL, Tejada-Vera B (2010) United States life tables, 2005. Natl Vital Stat Rep 58:1\u2013132","journal-title":"Natl Vital Stat Rep"},{"key":"4867_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/00005792-199611000-00002","volume":"75","author":"S Charache","year":"1996","unstructured":"Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, Ballas SK, McMahon RP, Castro O, Orringer EP (1996) Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive \u201cswitching\u201d agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Medicine (Baltimore) 75:300\u2013326. https:\/\/doi.org\/10.1097\/00005792-199611000-00002","journal-title":"Medicine (Baltimore)"},{"key":"4867_CR7","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1182\/asheducation-2014.1.432","volume":"2014","author":"TW Buckner","year":"2014","unstructured":"Buckner TW, Ataga KI (2014) Does hydroxyurea prevent pulmonary complications of sickle cell disease? Hematol Am Soc Hematol Educ Program 2014:432\u2013437","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"4867_CR8","unstructured":"Centers for Disease Control and Prevention (CDC). Sickle cell data collection data brief: hydroxyurea use among Medicaid beneficiaries with sickle cell disease in California and Georgia, 2006\u20132016. <https:\/\/www.cdc.gov\/ncbddd\/hemoglobinopathies\/scdc-hydruxyurea-data-brief.html>. Accessed 24 December 2021."},{"key":"4867_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1056\/NEJMoa1715971","volume":"379","author":"Y Niihara","year":"2018","unstructured":"Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E (2018) A phase 3 trial of L-glutamine in sickle cell disease. N Engl J Med 379:226\u2013235. https:\/\/doi.org\/10.1056\/NEJMoa1715971","journal-title":"N Engl J Med"},{"key":"4867_CR10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1182\/blood-2018-03-834440","volume":"132","author":"CT Quinn","year":"2018","unstructured":"Quinn CT (2018) L-Glutamine for sickle cell anemia: more questions than answers. Blood 132:689\u2013693. https:\/\/doi.org\/10.1182\/blood-2018-03-834440","journal-title":"Blood"},{"key":"4867_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1182\/blood-2007-04-081703","volume":"111","author":"CR Morris","year":"2008","unstructured":"Morris CR, Suh JH, Hagar W, Larkin S, Bland DA, Steinberg MH, Vichinsky EP, Shigenaga M, Ames B, Kuypers FA, Klings ES (2008) Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood 111:402\u2013410. https:\/\/doi.org\/10.1182\/blood-2007-04-081703","journal-title":"Blood"},{"key":"4867_CR12","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1182\/blood.V71.2.512.512","volume":"71","author":"CR Zerez","year":"1988","unstructured":"Zerez CR, Lachant NA, Lee SJ, Tanaka KR (1988) Decreased erythrocyte nicotinamide adenine dinucleotide redox potential and abnormal pyridine nucleotide content in sickle cell disease. Blood 71:512\u2013515. https:\/\/doi.org\/10.1182\/blood.V71.2.512.512","journal-title":"Blood"},{"key":"4867_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000063062","volume":"108","author":"AK Al-Ali","year":"2002","unstructured":"Al-Ali AK (2002) Pyridine nucleotide redox potential in erythrocytes of Saudi subjects with sickle cell disease. Acta Haematol 108:19\u201322. https:\/\/doi.org\/10.1159\/000063062","journal-title":"Acta Haematol"},{"key":"4867_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.bcmd.2017.05.009","volume":"70","author":"AI Alayash","year":"2018","unstructured":"Alayash AI (2018) Oxidative pathways in the sickle cell and beyond. Blood Cells Mol Dis 70:78\u201386. https:\/\/doi.org\/10.1016\/j.bcmd.2017.05.009","journal-title":"Blood Cells Mol Dis"},{"key":"4867_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2326-5-4","volume":"5","author":"Y Niihara","year":"2005","unstructured":"Niihara Y, Matsui NM, Shen YM, Akiyama DA, Johnson CS, Sunga MA, Magpayo J, Embury SH, Kalra VK, Cho SH, Tanaka KR (2005) L-glutamine therapy reduces endothelial adhesion of sickle red blood cells to human umbilical vein endothelial cells. BMC Blood Dis 5:4. https:\/\/doi.org\/10.1186\/1471-2326-5-4","journal-title":"BMC Blood Dis"},{"key":"4867_CR16","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3390\/nu10111564","volume":"10","author":"V Cruzat","year":"2018","unstructured":"Cruzat V, Rogero MM, Keane KN, Curi R, Newsholme P (2018) Glutamine: metabolism and immune function, supplementation and clinical translation. Nutrients 10:1564. https:\/\/doi.org\/10.3390\/nu10111564","journal-title":"Nutrients"},{"key":"4867_CR17","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1042\/BCJ20160103","volume":"473","author":"R Curi","year":"2016","unstructured":"Curi R, Newsholme P, Marzuca-Nassr GN, Takahashi HK, Hirabara SM, Cruzat V, Krause M, de Bittencourt Jr PI (2016) Regulatory principles in metabolism-then and now. Biochem J 473:1845\u20131857. https:\/\/doi.org\/10.1042\/BCJ20160103","journal-title":"Biochem J"},{"key":"4867_CR18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1146\/annurev.nu.11.070191.001441","volume":"11","author":"WW Souba","year":"1991","unstructured":"Souba WW (1991) Glutamine: a key substrate for the splanchnic bed. Annu Rev Nutr 11:285\u2013308. https:\/\/doi.org\/10.1146\/annurev.nu.11.070191.001441","journal-title":"Annu Rev Nutr"},{"key":"4867_CR19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0261-5614(03)00053-0","volume":"22","author":"B Wessner","year":"2003","unstructured":"Wessner B, Strasser EM, Spittler A, Roth E (2003) Effect of single and combined supply of glutamine, glycine, N-acetylcysteine, and R, S-alpha-lipoic acid on glutathione content of myelomonocytic cells. Clin Nutr 22:515\u2013522. https:\/\/doi.org\/10.1016\/S0261-5614(03)00053-0","journal-title":"Clin Nutr"},{"key":"4867_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s00431-002-1128-0","volume":"162","author":"Y Huang","year":"2003","unstructured":"Huang Y, Shao XM, Neu J (2003) Immunonutrients and neonates. Eur J Pediatr 162:122\u2013128. https:\/\/doi.org\/10.1007\/s00431-002-1128-0","journal-title":"Eur J Pediatr"},{"key":"4867_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12970-014-0061-8","volume":"11","author":"VF Cruzat","year":"2014","unstructured":"Cruzat VF, Krause M, Newsholme P (2014) Amino acid supplementation and impact on immune function in the context of exercise. J Int Soc Sports Nutr 11:61. https:\/\/doi.org\/10.1186\/s12970-014-0061-8","journal-title":"J Int Soc Sports Nutr"},{"key":"4867_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1006\/cyto.2000.0813","volume":"13","author":"M Co\u00ebffier","year":"2001","unstructured":"Co\u00ebffier M, Miralles-Barrachina O, Le Pessot F, Lalaude O, Daveau M, Lavoinne A, Lerebours E, D\u00e9chelotte P (2001) Influence of glutamine on cytokine production by human gut in vitro. Cytokine 13:148\u2013154. https:\/\/doi.org\/10.1006\/cyto.2000.0813","journal-title":"Cytokine"},{"key":"4867_CR23","first-page":"147","volume":"114","author":"TC Ko","year":"1993","unstructured":"Ko TC, Beauchamp RD, Townsend CM Jr, Thompson JC (1993) Glutamine is essential for epidermal growth factor-stimulated intestinal cell proliferation. Surgery 114:147\u2013153","journal-title":"Surgery"},{"key":"4867_CR24","doi-asserted-by":"publisher","first-page":"G943","DOI":"10.1152\/ajpgi.1997.272.5.G943","volume":"272","author":"JM Rhoads","year":"1997","unstructured":"Rhoads JM, Argenzio RA, Chen WU, Rippe RA, Westwick JK, Cox AD, Berschneider HM, Brenner DA (1997) L-glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases. Am J Physiol 272:G943\u2013G953. https:\/\/doi.org\/10.1152\/ajpgi.1997.272.5.G943","journal-title":"Am J Physiol"},{"key":"4867_CR25","doi-asserted-by":"publisher","first-page":"G866","DOI":"10.1152\/ajpgi.1996.271.5.G866","volume":"271","author":"TR Ziegler","year":"1996","unstructured":"Ziegler TR, Mantell MP, Chow JC, Rombeau JL, Smith RJ (1996) Gut adaptation and the insulin-like growth factor system: regulation by glutamine and IGF-I administration. Am J Physiol 271:G866\u2013G875. https:\/\/doi.org\/10.1152\/ajpgi.1996.271.5.G866","journal-title":"Am J Physiol"},{"key":"4867_CR26","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0039-6060(99)70264-3","volume":"125","author":"AT Blikslager","year":"1999","unstructured":"Blikslager AT, Rhoads JM, Bristol DG, Roberts MC, Argenzio RA (1999) Glutamine and transforming growth factor-a stimulate extracellular regulated kinases and enhance recovery of villous surface area in porcine ischemic-injured intestine. Surgery 125:186\u2013194. https:\/\/doi.org\/10.1016\/S0039-6060(99)70264-3","journal-title":"Surgery"},{"key":"4867_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1753-4887.1990.tb02967.x","volume":"48","author":"JM Lacey","year":"1990","unstructured":"Lacey JM, Wilmore DW (1990) Is glutamine a conditionally essential amino acid? Nutr Rev 48:297\u2013309. https:\/\/doi.org\/10.1111\/j.1753-4887.1990.tb02967.x","journal-title":"Nutr Rev"},{"key":"4867_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00726-008-0225-4","volume":"37","author":"JM Rhoads","year":"2009","unstructured":"Rhoads JM, Wu G (2009) Glutamine, arginine, and leucine signaling in the intestine. Amino Acids 37:111\u2013122. https:\/\/doi.org\/10.1007\/s00726-008-0225-4","journal-title":"Amino Acids"},{"key":"4867_CR29","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.bbamcr.2012.06.019","volume":"1823","author":"ML Circu","year":"2012","unstructured":"Circu ML, Aw TY (2012) Glutathione and modulation of cell apoptosis. Biochim Biophys Acta 1823:1767\u20131777. https:\/\/doi.org\/10.1016\/j.bbamcr.2012.06.019","journal-title":"Biochim Biophys Acta"},{"key":"4867_CR30","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S0891-5849(01)00480-4","volume":"30","author":"FQ Schafer","year":"2001","unstructured":"Schafer FQ, Buettner GR (2001) Redox environment of the cell as viewed through the redox state of the glutathione disulfide\/glutathione couple. Free Radic Biol Med 30:1191\u20131212. https:\/\/doi.org\/10.1016\/S0891-5849(01)00480-4","journal-title":"Free Radic Biol Med"},{"key":"4867_CR31","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/S0891-5849(99)00176-8","volume":"27","author":"OW Griffith","year":"1999","unstructured":"Griffith OW (1999) Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med 27:922\u2013935. https:\/\/doi.org\/10.1016\/S0891-5849(99)00176-8","journal-title":"Free Radic Biol Med"},{"key":"4867_CR32","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.bbadis.2011.04.011","volume":"1812","author":"E Nur","year":"2011","unstructured":"Nur E, Verwijs M, de Waart DR, Schnog JJ, Otten HM, Brandjes DP, Biemond BJ, Elferink RP, CURAMA Study Group (2011) Increased efflux of oxidized glutathione (GSSG) causes glutathione depletion and potentially diminishes antioxidant defense in sickle erythrocytes. Biochim Biophys Acta 1812:1412\u20131417. https:\/\/doi.org\/10.1016\/j.bbadis.2011.04.011","journal-title":"Biochim Biophys Acta"},{"key":"4867_CR33","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1046\/j.1365-2362.1999.00447.x","volume":"29","author":"A Hall","year":"1999","unstructured":"Hall A (1999) The role of glutathione in the regulation of apoptosis. Eur J Clin Invest 29:238\u2013245. https:\/\/doi.org\/10.1046\/j.1365-2362.1999.00447.x","journal-title":"Eur J Clin Invest"},{"key":"4867_CR34","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00394-012-0416-3","volume":"52","author":"YC Hou","year":"2013","unstructured":"Hou YC, Chu CC, Ko TL, Yeh CL, Yeh SL (2013) Effects of alanyl-glutamine dipeptide on the expression of colon-inflammatory mediators during the recovery phase of colitis induced by dextran sulfate sodium. Eur J Nutr 52:1089\u20131098. https:\/\/doi.org\/10.1007\/s00394-012-0416-3","journal-title":"Eur J Nutr"},{"key":"4867_CR35","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/0148607110381407","volume":"35","author":"H Xue","year":"2011","unstructured":"Xue H, Sufit AJ, Wischmeyer PE (2011) Glutamine therapy improves outcome of in vitro and in vivo experimental colitis models. JPEN J Parenter Enteral Nutr 35:188\u2013197. https:\/\/doi.org\/10.1177\/0148607110381407","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"4867_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00726-009-0243-x","volume":"37","author":"TE Haynes","year":"2009","unstructured":"Haynes TE, Li P, Li X, Shimotori K, Sato H, Flynn NE, Wang J, Knabe DA, Wu G (2009) L-Glutamine or L-alanyl-L-glutamine prevents oxidant- or endotoxin-induced death of neonatal enterocytes. Amino Acids 37:131\u2013142. https:\/\/doi.org\/10.1007\/s00726-009-0243-x","journal-title":"Amino Acids"},{"key":"4867_CR37","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a000141","volume":"1","author":"M Karin","year":"2009","unstructured":"Karin M (2009) NF-kB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol 1:a000141. https:\/\/doi.org\/10.1101\/cshperspect.a000141","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4867_CR38","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev-immunol-032713-120236","volume":"32","author":"K Ganeshan","year":"2014","unstructured":"Ganeshan K, Chawla A (2014) Metabolic regulation of immune responses. Annu Rev Immunol 32:609\u2013634. https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120236","journal-title":"Annu Rev Immunol"},{"key":"4867_CR39","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1006\/bbrc.2002.6470","volume":"291","author":"V Malhotra","year":"2002","unstructured":"Malhotra V, Eaves-Pyles T, Odoms K, Quaid G, Shanley TP, Wong HR (2002) Heat shock inhibits activation of NF-\u03baB in the absence of heat shock factor-1. Biochem Biophys Res Commun 291:453\u2013457. https:\/\/doi.org\/10.1006\/bbrc.2002.6470","journal-title":"Biochem Biophys Res Commun"},{"key":"4867_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12967-019-1938-8","volume":"17","author":"D Dutta","year":"2019","unstructured":"Dutta D, Meth\u00e9 B, Amar S, Morris A, Lim SH (2019) Intestinal injury and gut permeability in sickle cell disease. J Transl Med 17:183. https:\/\/doi.org\/10.1186\/s12967-019-1938-8","journal-title":"J Transl Med"},{"key":"4867_CR41","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/bjh.17889","volume":"196","author":"M Poplawska","year":"2021","unstructured":"Poplawska M, Dutta D, Jayaram M, Salifu M, Chong NS, Lim SH (2021) Intestinal pathophysiological abnormalities in steady state and after vaso-occlusive crisis in murine sickle cell disease. Br J Haematol 196:777\u2013780. https:\/\/doi.org\/10.1111\/bjh.17889","journal-title":"Br J Haematol"},{"key":"4867_CR42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12967-018-1622-4","volume":"16","author":"SH Lim","year":"2018","unstructured":"Lim SH, Meth\u00e9 BA, Knoll BM, Morris A, Obaro SK (2018) Invasive non-typhoidal Salmonella in sickle cell disease in Africa: is increased gut permeability the missing link? J Transl Med 16:239. https:\/\/doi.org\/10.1186\/s12967-018-1622-4","journal-title":"J Transl Med"},{"key":"4867_CR43","doi-asserted-by":"publisher","first-page":"G467","DOI":"10.1152\/ajpgi.1995.269.4.G467","volume":"269","author":"JM Anderson","year":"1995","unstructured":"Anderson JM, Van Itallie CM (1995) Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol 269:G467\u2013G475. https:\/\/doi.org\/10.1152\/ajpgi.1995.269.4.G467","journal-title":"Am J Physiol"},{"key":"4867_CR44","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1146\/annurev.physiol.68.040104.131404","volume":"68","author":"CM Van Itallie","year":"2006","unstructured":"Van Itallie CM, Anderson JM (2006) Claudins and epithelial paracellular transport. Annu Rev Physiol 68:403\u2013429. https:\/\/doi.org\/10.1146\/annurev.physiol.68.040104.131404","journal-title":"Annu Rev Physiol"},{"key":"4867_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0079-6107(02)00037-8","volume":"81","author":"L Gonzalez-Mariscal","year":"2003","unstructured":"Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo B (2003) Tight junction proteins. Prog Biophys Mol Biol 81:1\u201344. https:\/\/doi.org\/10.1016\/S0079-6107(02)00037-8","journal-title":"Prog Biophys Mol Biol"},{"key":"4867_CR46","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nrm.2016.80","volume":"17","author":"C Zihni","year":"2016","unstructured":"Zihni C, Mills C, Matter K, Balda MS (2016) Tight junctions: from simple barriers to multifunctional molecular gates. Nat Rev Mol Cell Biol 17:564\u2013580. https:\/\/doi.org\/10.1038\/nrm.2016.80","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4867_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev.physiol.60.1.121","volume":"60","author":"LL Mitic","year":"1998","unstructured":"Mitic LL, Anderson JM (1998) Molecular architecture of tight junctions. Annu Rev Physiol 60:121\u2013142. https:\/\/doi.org\/10.1146\/annurev.physiol.60.1.121","journal-title":"Annu Rev Physiol"},{"key":"4867_CR48","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1749-6632.2012.06526.x","volume":"1258","author":"KE Cunningham","year":"2012","unstructured":"Cunningham KE, Turner JR (2012) Myosin light chain kinase: pulling the strings of epithelial tight junction function. Ann N Y Acad Sci 1258:34\u201342. https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06526.x","journal-title":"Ann N Y Acad Sci"},{"key":"4867_CR49","doi-asserted-by":"publisher","first-page":"7210","DOI":"10.2741\/3223","volume":"13","author":"R Rao","year":"2008","unstructured":"Rao R (2008) Oxidative stress-induced disruption of epithelial and endothelial tight junctions. Front Biosci 13:7210\u20137226. https:\/\/doi.org\/10.2741\/3223","journal-title":"Front Biosci"},{"key":"4867_CR50","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.bbamem.2007.08.018","volume":"1778","author":"L Gonzalez-Mariscal","year":"2008","unstructured":"Gonzalez-Mariscal L, Tapia R, Chamorro D (2008) Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 1778:729\u2013756. https:\/\/doi.org\/10.1016\/j.bbamem.2007.08.018","journal-title":"Biochim Biophys Acta"},{"key":"4867_CR51","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3945\/jn.108.101485","volume":"139","author":"N Li","year":"2009","unstructured":"Li N, Neu J (2009) Glutamine deprivation alters intestinal tight junctions via a PI3-K\/Akt mediated pathway in Caco-2 cells. J Nutr 139:710\u2013714. https:\/\/doi.org\/10.3945\/jn.108.101485","journal-title":"J Nutr"},{"key":"4867_CR52","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3945\/jn.115.224857","volume":"146","author":"B Wang","year":"2016","unstructured":"Wang B, Wu Z, Ji Y, Sun K, Dai Z, Wu G (2016) L-glutamine enhances tight junction integrity by activating CaMK kinase 2\u2013AMP-activated protein kinase signaling in intestinal porcine epithelial cells. J Nutr 146:501\u2013508. https:\/\/doi.org\/10.3945\/jn.115.224857","journal-title":"J Nutr"},{"key":"4867_CR53","doi-asserted-by":"publisher","unstructured":"Chanez-Paredes SD, Abtahi S, Kuo W-T, Turner JR (2021) Differentiating between tight junction-dependent and tight junction-independent intestinal barrier loss in vivo. In: Turksen K. (eds) Permeability Barrier. Methods in Molecular Biology, vol 2367. Humana, New York. https:\/\/doi.org\/10.1007\/7651_2021_389","DOI":"10.1007\/7651_2021_389"},{"key":"4867_CR54","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5217\/ir.2015.13.1.11","volume":"13","author":"SH Lee","year":"2015","unstructured":"Lee SH (2015) Intestinal permeability regulation by tight junction: Implication on inflammatory bowel diseases. Intest Res 13:11\u201318. https:\/\/doi.org\/10.5217\/ir.2015.13.1.11","journal-title":"Intest Res"},{"key":"4867_CR55","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nm.4358","volume":"23","author":"R Liu","year":"2017","unstructured":"Liu R, Hong J, Xu X et al (2017) Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med 23:859\u2013868. https:\/\/doi.org\/10.1038\/nm.4358","journal-title":"Nat Med"},{"key":"4867_CR56","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.clnu.2015.01.021","volume":"35","author":"P Jegatheesan","year":"2016","unstructured":"Jegatheesan P, Beutheu S, Ventura G, Sarfati G, Nubret E, Kapel N, Waligora-Dupriet AJ, Bergheim I, Cynober L, De-Bandt JP (2016) Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease. Clin Nutr 35:175\u2013182. https:\/\/doi.org\/10.1016\/j.clnu.2015.01.021","journal-title":"Clin Nutr"},{"key":"4867_CR57","doi-asserted-by":"publisher","first-page":"170","DOI":"10.2527\/jas.2008-1698","volume":"88","author":"S Chamorro","year":"2010","unstructured":"Chamorro S, de Blas C, Grant G, Badiola I, Menoyo D, Caraba\u00f1o R (2010) Effect of dietary supplementation with glutamine and a combination of glutamine-arginine on intestinal health in twenty-five-day-old weaned rabbits. J Anim Sci 88:170\u2013180. https:\/\/doi.org\/10.2527\/jas.2008-1698","journal-title":"J Anim Sci"},{"key":"4867_CR58","doi-asserted-by":"publisher","first-page":"4862861","DOI":"10.1155\/2017\/4862861","volume":"2017","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Lu T, Han L, Zhao L, Niu Y, Chen H (2017) L-glutamine supplementation alleviates constipation during late gestation of mini sows by modifying the microbiota composition in feces. BioMed Res Int 2017:4862861. https:\/\/doi.org\/10.1155\/2017\/4862861","journal-title":"BioMed Res Int"},{"key":"4867_CR59","doi-asserted-by":"publisher","first-page":"E91","DOI":"10.1002\/ajh.25019","volume":"93","author":"SH Lim","year":"2018","unstructured":"Lim SH, Morris A, Li K, Fitch AC, Fast L, Goldberg L, Quesenberry M, Sprinz P, Meth\u00e9 B (2018) Intestinal microbiome analysis revealed dysbiosis in sickle cell disease. Am J Hematol 93:E91\u2013E93. https:\/\/doi.org\/10.1002\/ajh.25019","journal-title":"Am J Hematol"},{"key":"4867_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255956","volume":"16","author":"H Brim","year":"2021","unstructured":"Brim H, Taylor J, Abbas M, Vilmenay K, Daremipouran M, Varma S, Lee E, Pace B, Song-Naba WL, Gupta K, Nekhai S, O\u2019Neil P, Ashktorab H (2021) The gut microbiome in sickle cell disease: characterization and potential implications. PLoS ONE 16:e0255956. https:\/\/doi.org\/10.1371\/journal.pone.0255956","journal-title":"PLoS ONE"},{"key":"4867_CR61","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/ibd.20543","volume":"14","author":"NA Kretzmann","year":"2008","unstructured":"Kretzmann NA, Fillmann H, Mauriz JL, Marroni CA, Marroni N, Gonz\u00e1lez-Gallego J, Tu\u00f1\u00f3n MJ (2008) Effects of glutamine on proinflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in TNBS-induced colitis. Inflamm Bowel Dis 14:1504\u20131513. https:\/\/doi.org\/10.1002\/ibd.20543","journal-title":"Inflamm Bowel Dis"},{"key":"4867_CR62","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/jn\/135.2.245","volume":"135","author":"KC Liboni","year":"2005","unstructured":"Liboni KC, Li N, Scumpia PO, Neu J (2005) Glutamine modulates LPS-induced IL-8 production through I\u03baB\/NF-\u03baB in human fetal and adult intestinal epithelium. J Nutr 135:245\u2013251. https:\/\/doi.org\/10.1093\/jn\/135.2.245","journal-title":"J Nutr"},{"key":"4867_CR63","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cyto.2003.12.008","volume":"26","author":"K Liboni","year":"2004","unstructured":"Liboni K, Li N, Neu J (2004) Mechanism of glutamine-mediated amelioration of lipopolysaccharide-induced IL-8 production in Caco-2 cells. Cytokine 26:57\u201365. https:\/\/doi.org\/10.1016\/j.cyto.2003.12.008","journal-title":"Cytokine"},{"key":"4867_CR64","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1600-0609.1998.tb01036.x","volume":"60","author":"CC Anyaegbu","year":"1998","unstructured":"Anyaegbu CC, Okpala IE, Akren\u2019Ova YA, Salimonu LS (1998) Peripheral blood neutrophil count and candidacidal activity correlate with the clinical severity of sickle cell anaemia (SCA). Eur J Haematol 60:267\u2013268. https:\/\/doi.org\/10.1111\/j.1600-0609.1998.tb01036.x","journal-title":"Eur J Haematol"},{"key":"4867_CR65","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/jlb.66.3.411","volume":"66","author":"LR Lard","year":"1999","unstructured":"Lard LR, Mul FP, de Haas M, Roos D, Duits AJ (1999) Neutrophil activation in sickle cell disease. J Leukoc Biol 66:411\u2013415. https:\/\/doi.org\/10.1002\/jlb.66.3.411","journal-title":"J Leukoc Biol"},{"key":"4867_CR66","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/ajh.20059","volume":"76","author":"AF Lum","year":"2004","unstructured":"Lum AF, Wun T, Staunton D, Simon SI (2004) Inflammatory potential of neutrophils detected in sickle cell disease. Am J Hematol 76:126\u2013133. https:\/\/doi.org\/10.1002\/ajh.20059","journal-title":"Am J Hematol"},{"key":"4867_CR67","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1073\/pnas.052522799","volume":"99","author":"A Turhan","year":"2002","unstructured":"Turhan A, Weiss LA, Mohandas N, Coller BS, Frenette PS (2002) Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proc Natl Acad Sci USA 99:3047\u20133051. https:\/\/doi.org\/10.1073\/pnas.052522799","journal-title":"Proc Natl Acad Sci USA"},{"key":"4867_CR68","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature15367","volume":"525","author":"D Zhang","year":"2015","unstructured":"Zhang D, Chen G, Manwani D, Mortha A, Xu C, Faith JJ, Burk RD, Kunisaki Y, Jang JE, Scheiermann C, Merad M, Frenette PS (2015) Neutrophil ageing is regulated by the microbiome. Nature 525:528\u2013532. https:\/\/doi.org\/10.1038\/nature15367","journal-title":"Nature"},{"key":"4867_CR69","doi-asserted-by":"publisher","first-page":"E325","DOI":"10.1002\/ajh.25637","volume":"94","author":"SH Lim","year":"2019","unstructured":"Lim SH, Dutta D, Moore J (2019) Rifaximin for sickle cell disease. Am J Hematol 94:E325\u2013E328. https:\/\/doi.org\/10.1002\/ajh.25637","journal-title":"Am J Hematol"},{"key":"4867_CR70","doi-asserted-by":"publisher","first-page":"E83","DOI":"10.1002\/ajh.25722","volume":"95","author":"D Dutta","year":"2020","unstructured":"Dutta D, Li K, Meth\u00e9 B, Lim SH (2020) Rifaximin on intestinally-related pathologic changes in sickle cell disease. Am J Hematol 95:E83\u2013E86. https:\/\/doi.org\/10.1002\/ajh.25722","journal-title":"Am J Hematol"},{"key":"4867_CR71","unstructured":"Bradt P, Spackman E, Synnott PG, Chapman R, Beinfeld M, Rind DM, and Pearson SD. Crizanlizumab, voxelotor, and L-glutamine for sickle cell disease: effectiveness and value. Institute for Clinical and Economic Review. 2020. https:\/\/icer.org\/wp-content\/uploads\/2020\/10\/ICER_SCD_Evidence-Report_031220-FOR-PUBLICATION.pdf."},{"key":"4867_CR72","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/ajh.25724","volume":"95","author":"MH Steinberg","year":"2020","unstructured":"Steinberg MH (2020) Treating sickle cell anemia: a new era dawns. Am J Hematol 95:338\u2013342. https:\/\/doi.org\/10.1002\/ajh.25724","journal-title":"Am J Hematol"},{"key":"4867_CR73","unstructured":"Emmaus Life Sciences Reports Increase in Sales Volume in 2020. <https:\/\/www.prnewswire.com\/news-releases\/emmaus-life-sciences-reports-increase-in-sales-volume-in-2020-301216439.html>. Accessed 2 December 2021."},{"key":"4867_CR74","doi-asserted-by":"publisher","first-page":"E38","DOI":"10.1002\/ajh.26021","volume":"96","author":"UO Ogu","year":"2021","unstructured":"Ogu UO, Thomas M, Chan F, Vattappally L, Sebastian G, Crouch A, You S, Minniti CP (2021) L-glutamine use in adults with sickle cell disease: clinical trials where success meets reality. Am J Hematol 96:E38\u2013E40. https:\/\/doi.org\/10.1002\/ajh.26021","journal-title":"Am J Hematol"},{"key":"4867_CR75","unstructured":"Emmaus withdraws European application for sickle cell drug that got US approval. <https:\/\/medcitynews.com\/2019\/09\/emmaus-withdraws-european-application-for-sickle-cell-drug-that-got-us-approval\/\/>. Accessed 2 December 2021."},{"key":"4867_CR76","unstructured":"Xyndari: Withdrawal of the marketing authorization application (2019) https:\/\/www.ema.europa.eu\/en\/documents\/withdrawal-report\/withdrawal-assessment-report-xyndari_en.pdf. Access 6 April 2022."}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04867-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-04867-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04867-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T13:07:28Z","timestamp":1657717648000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-04867-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,14]]},"references-count":76,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["4867"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-04867-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,14]]},"assertion":[{"value":"9 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}